New indication concerns a combination with pemetrexed and platinum for the first-line treatment of adult patients with unresectable non-epithelioid malignant pleural mesothelioma
Home World News EMA Recommends Extension of Indications for Pembrolizumab to Malignant Pleural Mesothelioma
